Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.23M Sell
422,029
-146,522
-26% -$419K 0.51% 44
2025
Q4
$1.4M Buy
568,551
+29,440
+5% +$70.1K 0.58% 37
2025
Q3
$1.2M Buy
539,111
+5,177
+1% +$11.8K 0.51% 43
2025
Q2
$1.29M Buy
533,934
+455,129
+578% +$1.11M 0.59% 41
2025
Q1
$184K Buy
78,805
+1,120
+1% +$2.24K 0.09% 149
2024
Q4
$144K Sell
77,685
-7,101
-8% -$15.7K 0.07% 152
2024
Q3
$207K Sell
84,786
-9,347
-10% -$21K 0.11% 146
2024
Q2
$193K Sell
94,133
-2,472
-3% -$5.63K 0.11% 143
2024
Q1
$240K Sell
96,605
-895
-0.9% -$2.33K 0.16% 136
2023
Q4
$273K Buy
+97,500
New +$263K 0.19% 125

Other funds holding ABEV

Burford Brothers's ABEV Position: Q1 2026 in Review

Burford Brothers reduced its Ambev (ABEV) stake by 26% in Q1 2026, selling an estimated $419K and leaving 422,029 shares worth $1.23M. The position accounts for 0.51% of the portfolio, ranked #44.

Burford Brothers first reported a position in ABEV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.4M in Q4 2025. 402 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Burford Brothers held 422,029 shares of Ambev worth $1.23M as of Q1 2026.
  • Burford Brothers sold 146,522 Ambev shares in Q1 2026, an estimated $419K.
  • Ambev made up 0.51% of Burford Brothers's portfolio in Q1 2026, its #44 holding.
  • Burford Brothers first reported a position in Ambev in Q4 2023 and has held it in 10 quarters since.
  • Burford Brothers's Ambev position peaked at $1.4M in Q4 2025.
  • 402 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Burford Brothers's 13F filing for Q1 2026, filed 27 Apr 2026.